The earliest signs of renal impairment in the diabetic patient traditionally marked the onset of an era of frustration for both physician and patient. Aside from meticulous control of hypertension, there was little to do to alter the inexorable course to dialysis or transplantation. However, if the recent reports touting the benefits of low-protein diets are correct, all of this may soon change; these diets may delay or prevent end-stage renal insufficiency. The question is whether these diets are safe as well as efficacious.
best remedy offered, much more must be known about the interactions of protein-restricted diets with diabetes to be sure that the benefits outweigh the risks.
ARE LOW-PROTEIN DIETS EFFECTIVE?
Protein-reduced diets for patients with renal insufficiency from various causes regularly produce a gratifying decline in both proteinuria and rates of creatinine clearance. For example, a 40-g/day protein diet given to patients with moderately advanced renal insufficiency (serum creatinine >5 mg/dl) blunts the decline in glomerular filtration and delays the time to the initiation of dialysis in excess of 27 mo (1). In subjects with even more severe renal insufficiency (serum creatinine of 10 mg/dl), an extremely low protein diet (20 g/day) supplemented with essential amino acids and their a-ketoanalogues postponed dialysis by an average of 11 mo (1).
This effect is also seen in insulin-dependent (type I) diabetic patients. Barsotti et al. (2) administered diets containing either 0.3 or 0.6 g • kg" 1 • day" 1 of protein supplemented with essential amino acids or ketoacids to patients with creatinine clearances of <45 ml/min. The rate of decline in creatinine clearance changed from 1.38 to 0.03 ml • min" 1 • mo" 1 during the 17.4 mo of dietary therapy. Evanoffetal. (3) obtained similar results during 12 mo of a 40-g/day protein restriction. The beneficial effect is even seen among type I patients with very early nephropathy (elevated urinary albumin excretion rate but normal serum creatinine). For example, Cohen et al. (4), with a 47-g/day protein diet, showed a 33% drop in 24-h albumin excretion in a 3-wk followup of type I diabetic subjects with minimally elevated albumin excretion (15-200 (xg/min).
WHAT ARE RISKS OF DIETARY PROTEIN RESTRICTION IN DIABETIC PATIENTS?
The pool of data is disconcertingly small. The amount and type of proteins needed to maintain nutritional balance in diabetic patients with renal impairment is unknown. For comparison, the World Health Organization recommends at least 0.75 g • kg"
1 * day" 1 of protein intake to ensure adequate protein nutrition in healthy people. Most therapeutic protein-restricted diets provide a maximum of 0.6 g • kg" 1 • day" 1 , an amount that produced a marked drop in whole-body protein synthesis rates in normal volunteers (5) . In an uncontrolled but nevertheless disturbing observation, Lucas et al. (6) found evidence for reduced muscle mass without change in visceral proteins in 9 of 12 nondiabetic patients given a ketoacid-supplemented very low protein diet.
Because circulating insulin and amino acid concentrations separately influence protein synthesis, even more dramatic changes in protein metabolism in diabetic patients might be expected (7) . Furthermore, nitrogen balance may only be achieved during this dietary therapy at the expense of a retardation in protein turnover. Will this lead to increased accumulation of advanced glycosylation end products in structural proteins?
Another concern is altering the types of fat and ratio of fat to CHO in the diabetic diet. Replacing protein calories with CHO or fat may produce adverse changes in plasma lipid concentrations and lipoprotein structure and metabolism. Very little is known about these aspects of protein-reduced diets. Studies that have examined the issue and reported declines in serum triglyceride and cholesterol have not controlled the important variable of calorie intake (8) (9) (10) . Regardless of the direction of change in lipid concentrations, more subtle differences in lipoprotein structure, synthesis, and clearance rates may still affect atherogenesis. These changes may take place among a population already suffering from three times the risk of cardiovascular atherosclerotic disease at a given cholesterol level than their nondiabetic agematched counterparts (11) .
Finally, the effect of low-protein diets on glycemic control and insulin sensitivity are unclear, and available data are contradictory. Improved insulin response, as assessed by the hyperinsulinemic clamp technique, occurs in both uremic children and adults on low-protein diets (12, 13) . On the other hand, some studies find no change in either glycemia or insulin dosage during protein restriction (14, 15) .
There are many questions and few answers. Although not directed toward diabetic renal disease, ongoing long-term studies such as the multicenter Modification of Diet in Renal Disease trial, sponsored by the National Institutes of Health, may provide some insights. However, studies of diabetic patients are needed to rule out the potential metabolic disturbances that may accompany such therapy. These diets are radical departures from established practices, and they tip the diabetic dietary balance between protein, CHO, and fat. Are we saving the kidney while ignoring the rest of the body? This sort of question keeps some of us firmly planted to the pavement and cautiously committed to only modest protein restriction to the lower levels of the recommended daily allowance. We eagerly await the results of controlled long-term trials and studies of substrate metabolism in diabetic patients. IRWIN C. BRODSKY, MD, MPH DAVID C. ROBBINS, MD
